期刊文献+

microRNA与肝癌研究进展 被引量:3

下载PDF
导出
摘要 随着人类后基因组计划的进一步开展,占人类基因组99%的非编码序列日益引起科学家的关注,其中最引人注目的是 microRNA(以下简称 miRNA )的发现。miRNA是一类全长为18~25个核苷酸的单链小分子RNA,通过与靶标基因3’非翻译区(3’UTR)结合在转录后对靶标基因的表达水平进行调控[1]。
作者 邢茜 陈思宇
出处 《肿瘤基础与临床》 2014年第5期447-451,共5页 journal of basic and clinical oncology
  • 相关文献

参考文献2

二级参考文献24

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献992

同被引文献19

  • 1Cun-Shuan Xu,Shou-Bing Zhang,Xiao-Guang Chen,Salman Rahman.Correlation analysis of liver tumor-associated genes with liver regeneration[J].World Journal of Gastroenterology,2007,13(24):3323-3332. 被引量:4
  • 2Shanshan Chen,Ming Ni,Bing Yu,Tingting Lv,Mengji Lu,Feili Gong.Construction and Identification of a Human Liver Specific MicroRNA Eukaryotic Expression Vector[J].Cellular & Molecular Immunology,2007,4(6):473-477. 被引量:18
  • 3Torbenson MS. Hepatocellular carcinoma[M]. Switzer- land: Springer International Publishing, 2015 .. 169-218.
  • 4Yang XA,Dong XY, Qiao H, et al. Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues [J]. Lab Invest, 2005, 85 (2) .. 205-213.
  • 5Yuen JW, Poon LS, Chan AS, et al. Activation of STAT3 by specific Galpha subunits and multiple Gbetagamma di- mers[J]. Int J Biochem Cell Biol,2010,42(6) : 1052-1059.
  • 6Liotta LA. Gene products which play a role in cancer in- vasion and metastasisFJ:. Breast Cancer Res Treat, 1988, 11(2) : 113-124.
  • 7Quesada V, Ord6fiez GR, Sdnchez LM, et al. The de- gradome database: mammalian proteases and diseases of proteolysis[J]. Nucleic Acids Res,2009,37(Database is- sue) .- D239-243.
  • 8Troussard AA,Costello P, Yoganathan TN, et al. The in- tegrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 ( MMP-9 ) [J]. Oncogene, 2000,19(48) : 5444-5452.
  • 9闫萌,王巍,杨小昂,张毓,尹艳慧,陈慰峰.FATE/BJ-HCC-2基因表达促进细胞增殖及肿瘤形成[J].中国生物化学与分子生物学报,2008,24(8):748-754. 被引量:2
  • 10贾音,张毅,费明钰,孙树汉.慢性乙肝患者外周血microRNAs的表达变化[J].第二军医大学学报,2010,31(12):1381-1383. 被引量:6

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部